R R Rubin

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial
    R R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Qual Life Res 22:2389-98. 2013
  2. doi Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 14:143-51. 2012
  3. ncbi Patient-reported outcomes and diabetes technology: a systematic review of the literature
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Pediatr Endocrinol Rev 7:405-12. 2010
  4. doi Factors associated with physician perceptions of and willingness to recommend inhaled insulin
    R R Rubin
    Department of Medicine and Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Curr Med Res Opin 27:285-94. 2011
  5. doi Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy
    Richard R Rubin
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diabetes Educ 37:5S-18S; quiz 19S-20S. 2011
  6. pmc Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes
    R R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Diabetologia 53:1581-9. 2010
  7. pmc Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, 946 East Piney Hill Road, Monkton, Baltimore, Maryland, MD 21111, USA
    Health Qual Life Outcomes 8:32. 2010
  8. doi Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:901-6. 2010
  9. ncbi Factors affecting use of insulin pens by patients with type 2 diabetes
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 31:430-2. 2008
  10. pmc Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 31:420-6. 2008

Detail Information

Publications48

  1. ncbi Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial
    R R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Qual Life Res 22:2389-98. 2013
    ..To evaluate effects of two behavioral weight-loss interventions (in-person, remote) on health-related quality of life (HRQOL) compared to a control intervention...
  2. doi Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 14:143-51. 2012
    ..Patient acceptance of new therapies is essential to their adoption and effective use...
  3. ncbi Patient-reported outcomes and diabetes technology: a systematic review of the literature
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Pediatr Endocrinol Rev 7:405-12. 2010
    ..Advanced diabetes technology should have benefits not only in terms of clinical outcomes, but also in terms of patient-reported outcomes...
  4. doi Factors associated with physician perceptions of and willingness to recommend inhaled insulin
    R R Rubin
    Department of Medicine and Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Curr Med Res Opin 27:285-94. 2011
    ..To examine predictors of physician perceptions of an inhaled insulin, willingness to prescribe that insulin, and estimates of patient initiation of therapy with that insulin...
  5. doi Crossing the technology divide: practical strategies for transitioning patients from multiple daily insulin injections to sensor-augmented pump therapy
    Richard R Rubin
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diabetes Educ 37:5S-18S; quiz 19S-20S. 2011
    ....
  6. pmc Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes
    R R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Diabetologia 53:1581-9. 2010
    ..To determine the associations of baseline depression symptoms and use of antidepressant medicines (ADMs) with baseline cardiovascular disease (CVD) risk factors in Look AHEAD (Action for Health in Diabetes) trial participants...
  7. pmc Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ)
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, 946 East Piney Hill Road, Monkton, Baltimore, Maryland, MD 21111, USA
    Health Qual Life Outcomes 8:32. 2010
    ....
  8. doi Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:901-6. 2010
    ..This study assessed patient-reported outcomes (PRO) for patients with type 2 diabetes treated by insulin pump therapy...
  9. ncbi Factors affecting use of insulin pens by patients with type 2 diabetes
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 31:430-2. 2008
    ..To assess factors that might affect patient use of insulin pens...
  10. pmc Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Care 31:420-6. 2008
    ..To assess the association between elevated depression symptoms or antidepressant medicine use on entry to the Diabetes Prevention Program (DPP) and during the study and the risk of developing diabetes during the study...
  11. pmc Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Diabetes Sci Technol 3:1402-10. 2009
    ....
  12. ncbi Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide use
    Richard R Rubin
    John Hopkins University School of Medicine, Baltimore, Maryland, USA
    Diabetes Educ 35:136-46. 2009
    ..Thus, it is important to understand how patients experience a new treatment...
  13. ncbi Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study
    M Peyrot
    Dept of Sociology, Loyola College, 45021 North Charles Street, Baltimore, MD 21210 2699, USA
    Diabetologia 49:279-88. 2006
    ..We assessed country-level and individual-level patterns in patient and provider perceptions of diabetes care...
  14. ncbi Levels and risks of depression and anxiety symptomatology among diabetic adults
    M Peyrot
    Loyola College Center for Social and Community Research, Baltimore, MD 21210 2699, USA
    Diabetes Care 20:585-90. 1997
    ..To determine levels of depression and anxiety symptoms among adults with diabetes and identify factors associated with increased risk...
  15. doi Effect of technosphere inhaled insulin on quality of life and treatment satisfaction
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Technol Ther 12:49-55. 2010
    ..This randomized controlled trial assessed the impact of Technosphere insulin (MannKind Corp., Valencia, CA) delivered via the MedTone inhaler (MannKind Corp.) on quality of life and treatment satisfaction in adults with type 2 diabetes...
  16. ncbi Psychological issues and treatments for people with diabetes
    R R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, USA
    J Clin Psychol 57:457-78. 2001
    ..Finally, we briefly present some potentially positive consequences of living with diabetes so that readers can be aware of the inspirational aspects of personal experience with this disease...
  17. doi Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system
    Mark Peyrot
    Department of Sociology, Loyola College in Maryland, Baltimore, 21210 2699, USA
    Diabetes Technol Ther 11:57-62. 2009
    ....
  18. doi Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial
    M Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, MD, USA
    Diabet Med 30:464-7. 2013
    ....
  19. doi Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
    Mark Peyrot
    Loyola University Maryland, Baltimore, MD 21210, USA
    Curr Med Res Opin 26:1047-54. 2010
    ..To determine whether treatment satisfaction and quality of life were affected by adding mealtime pramlintide or rapid-acting insulin analogs (RAIAs) to basal insulin therapy for patients with inadequately controlled type 2 diabetes...
  20. ncbi Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Curr Med Res Opin 23:1919-29. 2007
    ..Assessment included the association between treatment satisfaction and clinical outcomes (changes in post-prandial glucose [PPG], glycosylated hemoglobin [HbA(1c)], weight, and insulin requirements)...
  21. ncbi Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies
    Richard R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diabetes Care 27:2495-7. 2004
  22. pmc Correlates of insulin injection omission
    Mark Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA
    Diabetes Care 33:240-5. 2010
    ..The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections...
  23. ncbi Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy
    Mark Peyrot
    Department of Sociology, Loyola College in Maryland, Baltimore, MD 21210, USA
    Diabetes Technol Ther 10:461-6. 2008
    ..This study was designed to assess diabetes-related distress and its association with clinical outcomes in patients with type 2 diabetes using basal insulin who were treated with pramlintide...
  24. ncbi Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire
    Mark Peyrot
    Department of Sociology and Center for Social and Community Research, Loyola College, Baltimore, Maryland 21210 2699, USA
    Diabetes Care 28:53-8. 2005
    ..To provide a preliminary assessment of the validity and reliability of a new measure of health-related quality of life (HRQOL) and treatment preference for insulin delivery systems...
  25. ncbi Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study
    M Peyrot
    Loyola College, Baltimore, MD 21210, USA
    Diabet Med 22:1379-85. 2005
    ..To examine patient- and provider-reported psychosocial problems and barriers to effective self-care and resources for dealing with those barriers...
  26. pmc How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, Maryland
    Diabetes Care 32:1411-7. 2009
    ..Perceived treatment consequences mediated the effect of objective clinical benefits on satisfaction with and preference for the study medication...
  27. doi Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ)
    M Peyrot
    Department of Sociology, Loyola University Maryland, Baltimore, MD, USA
    Diabet Med 29:1060-6. 2012
    ....
  28. ncbi Quality of life and diabetes
    R R Rubin
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Diabetes Metab Res Rev 15:205-18. 1999
    ..Methodologically, it is important to use multidimensional assessments of quality of life, and to include both generic and disease-specific measures. Quality of life measures should be used to guide and evaluate treatment interventions...
  29. pmc STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects
    Stephen N Davis
    Diabetes Endocrinology, Department of Medicine, Vanderbilt University, 2213 Garland Avenue, Nashville, TN 37232 0475, USA
    Diabetes Technol Ther 12:249-55. 2010
    ..Sensor-Augmented Pump Therapy for A1c Reduction (STAR) 3 is a multicenter randomized controlled trial comparing the efficacy of SAPT to that of MDI in subjects with type 1 diabetes...
  30. ncbi Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, MD 21210 2699, USA
    Diabetes Care 28:2673-9. 2005
    ..To examine the correlates of patient and provider attitudes toward insulin therapy...
  31. doi Addressing barriers to initiation of insulin in patients with type 2 diabetes
    Mark Peyrot
    Loyola University Maryland, Baltimore, Maryland, USA
    Prim Care Diabetes 4:S11-8. 2010
    ....
  32. doi Barriers to insulin injection therapy: patient and health care provider perspectives
    Richard R Rubin
    Department of Medicine, Hopkins University, Baltimore, Maryland, USA
    Diabetes Educ 35:1014-22. 2009
    ..To compare patients' perceptions of injection-related problems with clinicians' estimates of those problems...
  33. ncbi Health care and patient-reported outcomes: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
    Richard R Rubin
    Department of Medicine, The Johns Hopkins University, Baltimore, MD, USA
    Diabetes Care 29:1249-55. 2006
    ..The purpose of this study was to assess the relationship of patients' self-reported well-being, self-management, and diabetes control with factors related to the patient's health care...
  34. ncbi Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus
    Richard R Rubin
    Department of Medicine and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21210, USA
    Am J Med 118:27S-34S. 2005
    ..This article offers specific suggestions for improving adherence in patients with type 2 DM seen in general clinical practice...
  35. ncbi Recognizing and treating depression in patients with diabetes
    Richard R Rubin
    Departments of Medicine and Pediatrics, Johns Hopkins University School of Medicine, 500 West University Parkway, Baltimore, MD 21210, USA
    Curr Diab Rep 4:119-25. 2004
    ..They suggest that pharmacologic and psychological approaches are effective in the face of diabetes, and that successful treatment also produces improvements in glycemic control, overall functioning, and quality of life...
  36. doi Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus
    Mark Peyrot
    Department of Sociology, Loyola College, Baltimore, MD 21210 2699, USA
    Curr Med Res Opin 24:2413-22. 2008
    ..To determine the way in which physicians perceive insulin pens and the factors that affect their recommendations and their patients' pen initiation/use...
  37. doi Access to diabetes self-management education
    Mark Peyrot
    Department of Sociology, Loyola College and the Department of Medicine, John Hopkins University, Baltimore, MD, USA
    Diabetes Educ 34:90-7. 2008
    ....
  38. doi Access to diabetes self-management education: results of national surveys of patients, educators, and physicians
    Mark Peyrot
    Department of Sociology, Loyola College, 4501 North Charles Street, Baltimore, MD 21210 2699, USA
    Diabetes Educ 35:246-8, 252-6, 258-63. 2009
    ....
  39. pmc Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
    Allan F Moore
    Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    Diabetes 57:2503-10. 2008
    ....
  40. ncbi Physician and nurse use of psychosocial strategies in diabetes care: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
    Mark Peyrot
    Department of Sociology, Loyola College, 4501 North Charles St, Baltimore, MD 21210 2699, USA
    Diabetes Care 29:1256-62. 2006
    ..To determine the use of psychosocial strategies by health care providers in treating patients with diabetes and the factors associated with use of these strategies...
  41. pmc Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants
    Richard R Rubin
    Diabetes Prevention Program Coordinating Center, Biostatistics Center, 6110 Executive Boulevard, Suite 750, Rockville, MD 20852, USA
    Diabetes Care 28:830-7. 2005
    ....
  42. ncbi The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument
    Loretta Vileikyte
    Departments of Medicine and Behavioral Science, Manchester Royal Infirmary, Manchester, UK
    Diabetes Care 26:2549-55. 2003
    ....
  43. ncbi Was Willis right? Thoughts on the interaction of depression and diabetes
    Richard R Rubin
    Diabetes Metab Res Rev 18:173-5. 2002
    ..Future studies should establish a causal relationship between depression and the occurrence of type 2 diabetes, as well as possible mechanisms to explain the relationship, should one be observed...
  44. ncbi Diabetic peripheral neuropathy and depressive symptoms: the association revisited
    Loretta Vileikyte
    Department of Medicine, University of Manchester, UK
    Diabetes Care 28:2378-83. 2005
    ..We examined the association between severity of diabetic peripheral neuropathy and depressive symptoms and investigated the potential mediators of this association...
  45. ncbi US nurses' perceptions of their role in diabetes care: results of the cross-national Diabetes Attitudes Wishes and Needs (DAWN) study
    Linda M Siminerio
    University of Pittsburgh Diabetes Institute, Pittsburgh, PA 15213 3215, USA
    Diabetes Educ 33:152-62. 2007
    ..The purpose of this study was to examine nurse and physician perceptions of nurse involvement and roles in diabetes care...
  46. ncbi Patient Interpretation of Neuropathy (PIN) questionnaire: an instrument for assessment of cognitive and emotional factors associated with foot self-care
    Loretta Vileikyte
    Department of Medicine, University of Manchester, Oxford Road, Manchester M13 WL9, U K
    Diabetes Care 29:2617-24. 2006
    ..Using the common-sense model of illness behavior, we developed and validated a self-report instrument for assessment of patients' cognitive and emotional representations of diabetic peripheral neuropathy (DPN) influencing foot self-care...
  47. ncbi Behavioral and psychosocial interventions in diabetes: a conceptual review
    Mark Peyrot
    Diabetes Care 30:2433-40. 2007
  48. ncbi The Diabetes Prevention Program: recruitment methods and results
    Richard R Rubin
    DPP Coordinating Center, The Biostatistics Center, George Washington University, 61100 Executive Blvd, Suite 750, Rockville, MD 20852, USA
    Control Clin Trials 23:157-71. 2002
    ....